Institutional Ownership
Xeris Biopharma Holdings Inc
CUSIP 98422E103COMXERSQ1 2026
Institutional Holders
235
13F filers
Shares Held
105.18M
Aggregate institutional
Institutional Value
$599.39M
Q1 2026
Net New Holders
+11
40 new · 29 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions40
Increased99
Decreased56
Sold out29
Institutional Holders
235 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 12.95M | $75.09M | +306.5K | Added |
| 2 | D. E. Shaw & Co., Inc. | 7.79M | $45.18M | +214.0K | Added |
| 3 | Vanguard Capital Management LLC | 6.98M | $40.49M | +6.98M | First Filing |
| 4 | State Street Corp | 4.66M | $27.02M | +541.3K | Added |
| 5 | Geode Capital Management, LLC | 4.29M | $24.89M | +14.6K | Added |
| 6 | Qube Research & Technologies Ltd | 4.11M | $23.86M | +616.2K | Added |
| 7 | Rosalind Advisors, Inc. | 3.23M | $18.74M | +1.12M | Added |
| 8 | Nuveen, LLC | 2.92M | $16.92M | +109.8K | Added |
| 9 | Vanguard Portfolio Management LLC | 2.67M | $15.46M | +2.67M | First Filing |
| 10 | Morgan Stanley | 2.57M | $14.92M | −135.1K | Reduced |
225 more institutional holders on Premium
See every fund holding Xeris Biopharma Holdings Inc, with full quarter-over-quarter share changes.
Unlock all holders